EUVIMEDEUVIMED entdecken
Kohortenstudie

Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study

Arnar B Ingason, Johann P Hreinsson, Arnar S Agustsson, Sigrun H Lund, Edward Rumba, Daniel A Palsson, Indridi E Reynisson, Brynja R Gudmundsdottir, Pall T Onundarson, Einar S Bjornsson

Clinical Gastroenterology and Hepatology · 2023-02 · 21 (2) · 347-357.e10

DOI: 10.1016/j.cgh.2022.06.033 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-02. Verfasst von Arnar B Ingason und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykj…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Icelandic Centre for Research, Landspítali Háskólasjúkrahús.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: While overall gastrointestinal bleeding (GIB) rates have been extensively compared between warfarin and direct oral anticoagulants (DOACs), it is still unclear whether upper and lower GIB rates differ between these types of drugs. This study aimed to compare upper and lower GIB rates between warfarin and DOACs in a nationwide cohort. METHODS: Data on all patients in Iceland who received a prescription for oral anticoagulation from 2014 to 2019 were collected and their personal identification numbers linked to the electronic medical record system of the National University Hospital of Iceland and the 4 regional hospitals in Iceland. Inverse probability weighting was used to yield balanced study groups and rates of overall, major, upper, and lower GIB were compared using Cox regression. All GIB events were manually confirmed by chart review. RESULTS: Warfarin was associated with higher rates of upper GIB (1.7 events per 100 person-years vs 0.8 events per 100 person-years; hazard ratio [HR], 2.12; 95% confidence interval [CI], 1.26-3.59) but similar rates of lower GIB compared with DOACs. Specifically, warfarin was associated with higher rates of upper GIB compared with apixaban (HR, 2.63; 95% CI, 1.35-5.13), dabigatran (5.47; 95% CI, 1.87-16.05), and rivaroxaban (HR, 1.74; 95% CI, 1.00-3.05). Warfarin was associated with higher rates of major GIB compared with apixaban (2.3 events per 100 person-years vs 1.5 events per 100 person-years; HR, 1.79; 95% CI, 1.06-3.05), but otherwise overall and major GIB rates were similar in warfarin and DOAC users. CONCLUSIONS: Warfarin was associated with higher rates of upper but not overall or lower GIB compared with DOACs. Warfarin was associated with higher rates of major GIB compared with apixaban.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationStrokeHumansWarfarinAnticoagulantsCohort StudiesGastrointestinal HemorrhageDabigatranAdministration, OralRetrospective Studies

Stichwörter der Autor:innen

Direct Oral AnticoagulantsGastrointestinal BleedingMajor BleedingWarfarin

Substanzen

WarfarinAnticoagulantsDabigatran

Autor:innen und Institutionen

  • Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland.
  • Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • DeCODE Genetics, Reykjavik, Iceland.
  • Primary Health Care of the Capital Area, Reykjavik, Iceland.
  • Department of Laboratory Hematology and Coagulation Disorders, Landspitali University Hospital, Reykjavik, Iceland.
  • Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Laboratory Hematology and Coagulation Disorders, Landspitali University Hospital, Reykjavik, Iceland.

Förderung

  • Icelandic Centre for Research
  • Landspítali Háskólasjúkrahús

Zitieren

APA

Ingason, A. B., Hreinsson, J. P., Agustsson, A. S., Lund, S. H., Rumba, E., Palsson, D. A., Reynisson, I. E., Gudmundsdottir, B. R., Onundarson, P. T., & Bjornsson, E. S. (2023). Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study. Clinical Gastroenterology and Hepatology, 21(2), 347-357.e10. https://doi.org/10.1016/j.cgh.2022.06.033

Vancouver

Ingason AB, Hreinsson JP, Agustsson AS, Lund SH, Rumba E, Palsson DA, et al. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study. Clinical Gastroenterology and Hepatology. 2023;21(2):347-357.e10. doi:10.1016/j.cgh.2022.06.033

BibTeX
@article{Ingason2023,
  author = {Ingason, Arnar B and Hreinsson, Johann P and Agustsson, Arnar S and Lund, Sigrun H and Rumba, Edward and Palsson, Daniel A and Reynisson, Indridi E and Gudmundsdottir, Brynja R and Onundarson, Pall T and Bjornsson, Einar S},
  title = {Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {2},
  pages = {347--357.e10},
  doi = {10.1016/j.cgh.2022.06.033}
}
Kostenlos starten →